ファイザー社 利益予想を上回り 2025年の見通しを引き上げ 株主からの大きな動きを目撃しました Pfizer beat earnings estimates, raised 2025 outlook, and saw major shareholder activity.

ファイザー社は8月5日に第2四半期に強い業績を報告し,0.78ドルのEPSを投稿し,0.20ドルの見積もりを超え,14.65億ドルの収益を生み出し,前年比10.3%増加しました. Pfizer Inc. reported strong second-quarter results on August 5th, posting $0.78 EPS, exceeding estimates by $0.20, and generating $14.65 billion in revenue, a 10.3% year-over-year increase. 同社は2025年度の完全EPSガイドラインを2.90-3.10に上げ,年収の6.9%を1.72ドルで維持している. The company raised its full-year 2025 EPS guidance to $2.90–$3.10 and maintains a 6.9% dividend yield with a $1.72 annual payout. 多数の企業が同社の株式を調整した.その中には,Cwm LLCが6.0%のポジションを増やし,CCG Wealth Management LLCが47.3%の保有額を増やし,Strengthening Families & Communities LLCが871.3%の株式を増やした. Multiple firms adjusted their stakes in the company, including Cwm LLC increasing its position by 6.0%, CCG Wealth Management LLC raising its holdings by 47.3%, and Strengthening Families & Communities LLC boosting its stake by 871.3%. JFS資産アドバイザーLLCは676株の保有を減少させた. JFS Wealth Advisors LLC reduced its holding by 676 shares. 株式は"維持"評価と2. 8.35の目標価格を有する. The stock has a consensus "Hold" rating and a target price of $28.35.